NHS England has poured investment into hospitals while neglecting other parts of the service, Lord Ara Darzi concluded last year in his report on a “broken system”. The share of the UK health budget ...

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

It plans to invest $50 billion in the US over five years, including building its largest-ever manufacturing facility in ...

Europe's pharmaceutical companies are bracing for United States President Donald Trump's plan to slap tariffs of up to 250 ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

President Donald Trump has given major pharmaceutical companies 60 days to slash prescription drug prices or face action.

The global trading system is adjusting to the tariffs levied by the United States: for most goods they look likely to settle ...

Glencore said it had shelved plans to move its main listing to New York, adding that it believed a switch to Wall Street ...

From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.

Glencore has axed plans to move its main stock market listing away from London, in a boost for the London Stock Exchange.